Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris®

Stock Information for Cipher Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Cipher Pharmaceuticals Reports Second Quarter 2026 Results
Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call
Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders
Cipher Pharmaceuticals Reports First Quarter Results
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call
Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.